Searched for
DRUG RESISTANT PATHOGENS
Why people recommend putting orange peels in the toilet once a week, but only for 20 minutesA viral TikTok hack suggests using orange peels to freshen toilets, and science backs it up. The peels contain limonene, a natural compound...- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- USFDA accepts Wockhardt’s NDA for breakthrough antibiotic ZaynichThis is the first time ever that an NDA from a new chemical entity (NCE) from an Indian pharma company has been filed and accepted by the U...
- Wockhardt shares rise 10% after Zaynich aids successful liver transplant trialWockhardt's shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemo...
- How an 80-year-old antibiotic can become a wonder drug to defeat world's most dangerous infectionsResearchers are studying streptothricin, an old antibiotic, for its potential to fight drug-resistant superbugs. The antibiotic, now named ...
- 'Silent pandemic' danger: Fungal infections could be the next health crisis, scientists warnFungal infections are becoming increasingly resistant to medications, posing a significant global health threat. Researchers warn that thes...
- New AI model predicts personalised TB treatments, study showsA new artificial intelligence (AI) model developed by scientists has the potential to revolutionise tuberculosis (TB) treatment by predicti...
- AMR action: Kerala to cancel licences of pharmacies selling antibiotics without prescriptionThe WHO has said the emergence and spread of drug-resistant pathogens that have acquired new resistance mechanisms continues to threaten ou...
- ICMR issues guidelines against use of antibiotics for low-grade fever"A clinical diagnosis most often helps us predict causative pathogens fitting into a clinical syndrome which would tailor the correct antib...
- Sustained rise in antimicrobial resistance in India: ICMR studyThis is the fifth detailed report on antimicrobial resistance (AMR) trends and patterns from the country published by the ICMR. This year's...
- Wockhardt gets QIDP designation from USFDA for its combination antibioticThe QIDP status is granted to drugs that are effective against a set of multi-drug resistant pathogens identified by the Centre for Disease...
- Wockhardt gets DGCI approval for 2 new antibiotics"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial s...
- Are Indian pharma firms breeding superbugs, and should it scare us all?One study of a particular common pathogen in an Indian hospital found that about seven per cent of the specimens were resistant to even the...
- Wockhardt's WCK 771 and WCK 2349 recieve QIDP status from US FDAThis is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.
- Superbug: British researchers challenge India's standThe researchers have challenged the stand of Indian health authorities who have been maintaining that drug-resistant pathogens such as the ...
Load More
